






Project: Regulation of inflammation by the neurokine TAFA4
About
We have demonstrated that the neurokine TAFA4, produced by sensory neurons in the skin, can promote tissue repair by directly acting on the anti-inflammatory and pro-repair properties of macrophages (Hoeffel et al., Nature 2021). TAFA4 is capable of inducing IL-10 production by macrophages, but the molecular mechanisms involved remain poorly understood. Our project aims to identify the TAFA4 receptor on immune cells and to characterize the activated signaling pathways. We are also exploring in which pathological contexts and in which tissues this molecule is produced.
At the same time, we are evaluating the therapeutic potential of TAFA4 in preclinical models of inflammatory diseases. This work is being carried out in collaboration with Temper Bio, a biotechnology company co-founded by Sophie Ugolini and supported by the start-up studio ArgoBio.